Showing results (161-170 of 186) with videos related to
Sort By:
Pageof 19
International Journal of Molecular Sciences|October 26, 2024
Immune Checkpoint Inhibitor Therapy and Associations with Clonal HematopoiesisAbhay Singh, Nuria Mencia Trinchant, Rahul Mishra, et al.Cell Reports|December 3, 2015
A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 SpeciesHongliang Zong, Alexander Gozman, Eloisi Caldas-Lopes, et al.Frontiers in Microbiology|October 26, 2017
Characterization of Four Multidrug Resistance Plasmids Captured from the Sediments of an Urban Coastal WetlandRyan T Botts, Brooke A Apffel, C J Walters, et al.Frontiers in Immunology|November 5, 2021
Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALLJuan Carlos Balandrán, José Dávila-Velderrain, Antonio Sandoval-Cabrera, et al.ACS Chemical Biology|June 18, 2014
Affinity purification probes of potential use to investigate the endogenous Hsp70 interactome in cancerAnna Rodina, Tony Taldone, Yanlong Kang, et al.Cancer Cell|March 31, 2015
Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivoDmitry Borkin, Shihan He, Hongzhi Miao, et al.Cell Reports|November 26, 2020
Clonal Hematopoiesis Before, During, and After Human SpaceflightNuria Mencia-Trinchant, Matthew J MacKay, Christopher Chin, et al.Cancer Discovery|April 15, 2017
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic ModifiersJacob L Glass, Duane Hassane, Bas J Wouters, et al.Ebiomedicine|July 19, 2016
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven CancersAnuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.Nature Chemical Biology|June 22, 2021
Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domainShirish Shukla, Weijiang Ying, Felicia Gray, et al.Pageof 19